Avelumab is a monoclonal antibody that targets the PD-L1 protein expressed on the surface of tumor cells, and it is used for the treatment of various types of cancer. Avelumab is marketed under the brand name Javelin, and it is approved by the US Food and Drug Administration (FDA) for the treatment of metastatic Merkel cell carcinoma and urothelial carcinoma. Clinical trials are conducted to evaluate the safety and efficacy of new treatments, including avelumab, for different types of cancer. If you are interested in participating in a clinical trial for avelumab, there are several resources you can use to find clinical trials in your area.
ClinicalTrials.gov is a database of clinical trials conducted worldwide, maintained by the National Institutes of Health (NIH). You can search for clinical trials for avelumab on ClinicalTrials.gov by using the search term “avelumab” or “Javelin.” You can also search for trials by location, type of cancer, and other criteria. The search results will provide you with information about the trial, including the location, eligibility criteria, and contact information for the trial sponsor or investigator.
Cancer centers are specialized hospitals and clinics that provide comprehensive cancer care, including clinical trials. Many cancer centers conduct clinical trials for new cancer treatments, including avelumab. You can search for cancer centers in your area by using the National Cancer Institute’s (NCI) Cancer Centers Program directory. The directory provides a list of NCI-designated cancer centers and other institutions that conduct cancer research and clinical trials.
Pharmaceutical companies that develop new cancer treatments, such as avelumab, often conduct clinical trials for their products. You can search for clinical trials sponsored by pharmaceutical companies by visiting their websites or by using the ClinicalTrials.gov database. The trial information provided by pharmaceutical companies may include additional details about the trial, such as the study design and the expected duration of the study.
Patient Advocacy Groups
Patient advocacy groups are organizations that support patients and their families affected by specific diseases, including cancer. Many patient advocacy groups provide information and resources about clinical trials for their specific disease. You can search for patient advocacy groups for your type of cancer by using the NCI’s list of Cancer Information Services or by searching online.
Clinical Trial Matching Services
There are several clinical trial matching services available that can help you find clinical trials for avelumab in your area. These services use advanced algorithms to match patients with clinical trials based on their medical history, location, and other criteria. Some of the clinical trial matching services include:
a. CenterWatch Clinical Trials Listing Service: CenterWatch is a website that provides a listing of clinical trials conducted worldwide. You can search for clinical trials for avelumab on the CenterWatch website by using the search term “avelumab” or “Javelin.”
b. EmergingMed: EmergingMed is a free clinical trial matching service that helps patients find clinical trials for their specific disease. You can create a profile on the EmergingMed website and receive notifications about clinical trials that match your profile.
c. Clinical Trial Connect: Clinical Trial Connect is an online platform that connects patients with clinical trials for new treatments. You can search for clinical trials for avelumab on the Clinical Trial Connect website by using the search term “avelumab” or “Javelin.”
In conclusion, there are several resources available to help you find clinical trials for avelumab in your area, including ClinicalTrials.gov, cancer centers, pharmaceutical companies, patient advocacy groups, and clinical trial matching services. Before participating in a clinical trial, it is important to discuss the risks and benefits of the trial with your healthcare provider and the study investigators.